We have enjoyed rapid growth in Asia since our launch in 2008. Our extraordinary growth is because of our ability to bring innovative and relevant products to our clients, enabling them to differentiate themselves in a demanding market.
Vasan Errakiah
Managing Director | Protection | Asia
The Asia insurance market is among the fastest growing in the world. When we established operations in Asia, it was with the aim of dramatically making a difference, challenging the status quo and bringing a positive impact to the marketplace. Responsible for servicing a variety of countries - all with unique requirements, languages and cultures - we are driven to showcase our adaptibility, foresight and superior client service. Our success and unprecedented expansion across the region proves that our fresh, responsive and reinvigorated approach was just what the market needed.
We pride ourselves on delivering quality, customised solutions to meet the unique and specific needs of our clients. We are open and transparent with the conclusions we draw from our analysis and are unafraid to share our insights with our clients, to ensure they are kept up-to-date with market trends.
Our team of experts work closely with our clients to provide the best solutions, which help them to grow new businesses. We have a strong track record in helping our clients provide innovative products and services that significantly benefit their business and customers in the long term.
Our commitment to providing the best products available is reinforced by our company's vision to lead the way in underwriting technology. Our underwriting manual, Ocean, and our underwriting technology system, UnderwriteMe, not only position us as a leader in the reinsurance industry globally, they also help to drive growth for our clients.
For more information, please contact us.
Our Asia leadership team brings together the best minds and years of experience in the protection business
Tyson Johnston
Managing Director | Asia Pacific and Global Strategy
Wallace Ong
Head of Southeast Asia | Protection
Sujin Park
Head of Underwriting & Claims | Protection | Asia
Lee Yoke Yin
Head of South Korea | Protection
Kenichi Kim
Head of Japan | Protection
Carole Ong
Head of Pricing | Protection | Asia
Medical Advances
Read our update on the impact of mortality from COVID-19.
Medical Advances
Lung cancer is often diagnosed at a late stage leading to poor prognosis for the individual. We look at how screening could have an impact.
Underwriting & Claims
Underwriting has been going through significant transformation over the last few years and continues to accelerate at an unprecedented pace. Traditionally seen as a barrier, there is now a growing opportunity to position underwriting as a strategic asset.
Protection
Big data analytics has been instrumental for (re)insurers aiming to boost performance, efficiency, and effectiveness.
Medical Advances
From emerging drugs which battle obesity to a review of the effectiveness of new blood tests both to detect cancer and to help slow down Alzheimer’s, we hope these insights help keep you up to date with the latest in medical research.
Medical Advances
Vaping is generally considered less harmful than smoking, however longer-term risks have not had time to emerge and could prove considerable.
Medical Advances
Despite broadly improving cancer mortality, some types of the disease are increasing in incidence
Protection
Consumer Duty has put increased focus on how much value different customers get from financial products. But how well is the protection industry serving different customer groups? Who are the most underserved groups, and what can the industry do to help serve these groups better?
Underwriting & Claims
Underwriting processes, practices and philosophies are changing with faster pace than we have ever experienced before.
Medical Advances
A new generation of drugs has now well and truly arrived aiming to improve weight loss. The drugs are heavily touted by celebrities and influencers, despite many of them having no medical need to lose weight. Obesity contributes significantly to some of the most common causes of death including heart disease and cancer, as well as affecting quality of life for millions. In this article we look at these increasingly available drugs offering hope to more people with obesity. We consider their potential to broadly improve health, and their limitations.
Medical Advances
Scientists successfully conducted early-stage trials which provide hope of a future cure for some of the most severe types of multiple sclerosis (MS).
Medical Advances
The world’s largest conference dedicated to the science and treatment of cancer took place in Chicago in early June. The American Society of Clinical Oncology’s annual meeting is a popular forum at which new scientific developments are often revealed.
Medical Advances
A recent review by WHO resulted in reclassification of pituitary adenoma as described in the article
Medical Advances
In 2023 we’ve seen soaring temperatures across the globe along with devastating storms and wildfires. Why is our climate changing and what impact is it having?
Medical Advances
Welcome to our first edition of Vital Insights. Here we’ve put together a collection of articles covering some of the major issues of the day with a specific focus on how they will impact mortality and morbidity.
Medical Advances
Total deaths from dementias in high-income countries have almost quadrupled in the last 20 years, yet so far medical science has very few answers. This article looks at the recent emergence of the first drugs which may be able to modify the effects of this terrifying disease
Medical Advances
COVID-19 has stolen the limelight from other respiratory viruses in recent years. However there are plenty of other common viruses which can have serious health consequences, among them Respiratory Syncytial Virus, or RSV.
Medical Advances
A new UN report reveals optimism about a possible end to the global AIDS epidemic
Medical Advances
Vaccine technologies have continued to improve greatly in recent years. However, vaccines are little use if people refuse to use them. Here we look at the precarious position of measles, a well-known but little-understood serious condition, which is held in check in most countries only because of high vaccine uptake.
Medical Advances
The International Agency for Research on Cancer (IARC), the cancer research arm of the WHO, recently classified the common sweetener aspartame as a possible cause of cancer in humans.
Protection
Beneath the Surface report 2023 We explored some of the key drivers of sustainability for the protection market. We undertook consumer research which combined with our medical and underwriting expertise and our deep understanding of the market, enabled us to create this report.
At Pacific Life Re you’ll be encouraged to contribute your skills and strengths at every opportunity, articulating your ideas in your own way. With flexibility, creativity and passion, you’ll have opportunities to develop globally and achieve your ambitions.
